Dalbavancin in Gram-positive periprosthetic joint infections-authors' response

J Antimicrob Chemother. 2023 May 3;78(5):1316. doi: 10.1093/jac/dkad069.

Authors

Sebastian Simon^{1

2}, Bernhard J H Frank¹, Susana Hartmann¹, Alexander Aichmair^{1

2}, Bo Söderquist^{3

4}, Jochen G Hofstaetter^{1

2}

Affiliations

¹ Michael Ogon Laboratory for Orthopaedic Research, Orthopaedic Hospital Vienna-Speising, Speisinger Straße 109, 1130 Vienna, Austria.
² Second Department, Orthopaedic Hospital Vienna-Speising, Speisinger Straße 109, 1130 Vienna, Austria.
³ School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
⁴ Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

PMID: 36964645
DOI: 10.1093/jac/dkad069

No abstract available

Publication types

Letter
Comment

MeSH terms

Teicoplanin* / therapeutic use

Substances

dalbavancin
Teicoplanin